/Companies

Apexian Pharmaceuticals

2 known investors

Find your way into Apexian Pharmaceuticals

Sign up to see every warm intro you have to Apexian Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Apexian Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Apexian Pharma is a biopharmaceutical company developing APX3330, an oral drug for treating Inflammatory Bowel Disease, including Crohn's disease and ulcerative colitis, as a single agent or in combination. It targets upstream modulation of inflammation for IBD patients who fail to achieve durable remission on current therapies.

Investors · 2

Frequently asked questions

What does Apexian Pharmaceuticals do?
Apexian Pharma is a biopharmaceutical company developing APX3330, an oral drug for treating Inflammatory Bowel Disease, including Crohn's disease and ulcerative colitis, as a single agent or in combination. It targets upstream modulation of inflammation for IBD patients who fail to achieve durable remission on current therapies.
Who are Apexian Pharmaceuticals's investors?
Apexian Pharmaceuticals's investors include Elevate Ventures, IU Ventures.